NewAmsterdam Pharma Co N.V. ($NAMS)
Filing Information
| Accession Number | 0001193125-26-365202 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 25, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
375,000
Total Value
$3,363,750.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Ordinary Shares | โ | Aug 24, 2026 | Exercise/Conversion | 125,000 | โ | โ | 194,302 | Indirect | See footnotes | View Details | |
Director | Ordinary Shares | โ | Aug 24, 2026 | Sale | 125,000 | $26.91 | $3,363,750.00 | 69,302 | Indirect | See footnotes | View Details | |
Director | Option (right to buy) | Derivative | Aug 24, 2026 | Exercise/Conversion | 125,000 | $0.00 | $0.00 | 395,229 | Indirect | See footnote | View Details |